Sartorius Stedim Biotech SA
· ISIN: FR0013154002
· EQS - Company News
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Sartorius Stedim Biotech SA
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
17 June 2025 04:00PM
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Sartorius Stedim Biotech SA
/ Key word(s): Expansion
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET/CEST
Aubagne, France | June 17, 2025Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess so...
Sartorius Stedim Biotech SA
16 April 2025 07:00AM
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sartorius Stedim Biotech SA
/ Key word(s): Quarter Results/Forecast
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 16-Apr-2025 / 07:00 CET/CEST
Aubagne, France | April 16, 2025
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sales revenue at 745 million euros, up 10.4...
Sartorius Stedim Biotech SA
25 March 2025 03:35PM
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech SA
/ Key word(s): AGM/EGM
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. 25-March-2025 / 15:35 CET/CEST
Aubagne, France | March 25, 2025
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.At today’s combined Annual Shareh...
Sartorius Stedim Biotech SA
17 February 2025 10:02AM
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech SA
/ Key word(s): Annual Results
Sartorius Stedim Biotech releases Universal Registration Document 2024 17-Feb-2025 / 10:02 CET/CEST
Aubagne, France | February 17, 2025
Sartorius Stedim Biotech releases Universal Registration Document 2024Sartorius Stedim Biotech, a leading partner of the biopharma ind...
Sartorius Stedim Biotech SA
07 February 2025 03:57PM
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Sartorius Stedim Biotech SA
/ Key word(s): Dividend
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 / 15:57 CET/CEST
Aubagne, February 7, 2025Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euro...
Sartorius Stedim Biotech SA
28 January 2025 07:04AM
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024
Sartorius Stedim Biotech SA
/ Key word(s): Annual Results/Quarter Results
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 28-Jan-2025 / 07:04 CET/CEST
Aubagne, France | January 28, 2025Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024
Sales revenue at 2,780 ...
Sartorius Stedim Biotech SA
17 October 2024 07:02AM
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024
Sartorius Stedim Biotech SA
/ Key word(s): 9 Month figures
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 17-Oct-2024 / 07:02 CET/CEST
Aubagne, France | October 17, 2024Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024
Sales revenue of 2,029 mill...
Sartorius Stedim Biotech SA
More Sartorius Stedim Biotech SA related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 0 | - | - | DD |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN